Diagnostic and Interventional Cardiology

Findings reveal AFib patients are fearful of complications from the condition, but not all are treating their AFib quicky after diagnosis

News | Atrial Fibrillation

Biosense Webster AFib Survey Findings Reveal Surprising Patient Behaviors and At-Risk Population Awareness Gaps

September 14, 2022 — In recognition of Atrial Fibrillation (AFib) Awareness Month, Biosense Webster, Inc., part of ...

September 14, 2022

Anthos Therapeutics has announced that Abelacimab has received FDA Fast Track Designation for the prevention of stroke and systemic embolism in patients with atrial fibrillation.

News | Stroke

Anthos Therapeutics Announces Abelacimab Received FDA Fast Track Designation for the Prevention of Stroke and Systemic Embolism in Patients with AFib

September 13, 2022 — Anthos Therapeutics, a clinical-stage biotechnology company developing innovative therapies for ...

September 13, 2022

Image showing a co-registration of invasive coronary angiography (A), coronary CTA and straight MPR (panel B and C) with CTA cross sections (panel D), corresponding OCT cross sections and longitudinal OCT view (E).

News | SCCT

CCTA Effective in Pre-procedural Planning of Myocardial Revascularization Interventions

September 13, 2022 — The latest expert consensus document from the Society of Cardiovascular Computed Tomography (SCCT) ...

September 13, 2022

Sponsored Content

ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services

Feature | Information Technology

SPONSORED CONTENT: Unveiling the Future of Cardiovascular Workflow

Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

March 21, 2024

The ŌNŌ endovascular retrieval system was recently used to remove a malpositioned leadless pacemaker (LPM) that embolized to the right pulmonary artery in a 52- year-old patient, ŌNŌCOR LLC announced.

News | Structural Heart

First-In-Human Use of the ŌNŌ Retrieval System for Percutaneous Removal of an Embolized Leadless Pacemaker from the Right Pulmonary Artery

September 13, 2022 — The ŌNŌ endovascular retrieval system was recently used to remove a malpositioned leadless ...

September 13, 2022

News | STEMI

First Patient Enrolled in AMIHOT III Trial Investigating ZOLL’s Supersaturated Oxygen Therapy in Heart Attack Patients

September 13, 2022 — ZOLL Medical Corporation, an Asahi Kasei company that manufactures medical devices and related ...

September 13, 2022

DAIC editors outline some highlights of what to expect from this year’s conference.

Feature | TCT | By Melinda Taschetta-Millane

Transcatheter Cardiovascular Therapeutics (TCT) 2022 Conference Preview

The Transcatheter Cardiovascular Therapeutics (TCT) conference, which is the Cardiovascular Research Foundation's (CRF) ...

September 12, 2022

Sponsored Content

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision

Feature | Cardiac Imaging

SPONSORED CONTENT: Finding the Right Solution

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...

March 05, 2024

WATCHMAN FLX now the only LAAC technology in the United States that allows for either DAPT or OAC immediately following implantation

News | Left Atrial Appendage (LAA) Occluders

Boston Scientific Receives FDA Approval for Expanded Labeling of WATCHMAN FLX LAAC Device for Dual Anti-Platelet Therapy as Post-Procedural Medication Option

September 12, 2022 — Boston Scientific Corporation has received U.S. Food and Drug Administration (FDA) approval to ...

September 12, 2022

Computed tomography 3D surface rendering of the lungs and heart from a patient with pulmonary arterial hypertension demonstrating trachea and major airways (yellow), an enlarged heart (red), enlarged main pulmonary artery (large blue vessel on top of heart) and thinning of the peripheral pulmonary vessels (blue). Marcus Y. Chen, M.D., NHLBI

News | Hypertension

Novel Blood Test Helps Evaluate Severity in Pulmonary Arterial Hypertension, a Rare Lung Disease

September 12, 2022 — Researchers at the National Institutes of Health have found that a novel blood test can be used to ...

September 12, 2022

News | SPECT-CT

Philips Announces New Milestones in the Development of the World’s First Spectral Detector Angio CT Solution

September 12, 2022 — Royal Philips, a global leader in health technology, announced new milestones in the development of ...

September 12, 2022

Sponsored Content

Blog

BLOG: Combining Local Impedance with Contact Force to Perform RF Ablation

When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...

December 11, 2023

The U.S. Food and Drug Administration (FDA) is alerting healthcare providers about potential clip lock malfunctions with MitraClip Clip Delivery Systems manufactured by Abbott.

News | Heart Valve Technology

FDA Alerts Healthcare Providers to Potential for Clip Lock Malfunctions in Abbott MitraClip Device

September 9, 2022 — The U.S. Food and Drug Administration (FDA) is alerting healthcare providers about potential clip ...

September 09, 2022

Results from ENVISAGE-TAVI AF show mortality risk score for AFib patients undergoing TAVR. Image courtesy of Mount Sinai Health System

News | Atrial Fibrillation

New Risk Score Predicts Mortality for Atrial Fibrillation Patients Undergoing Transcatheter Aortic Valve Replacement

September 9, 2 022 — A large-scale international study led by Mount Sinai has yielded the first risk score that can help ...

September 09, 2022

Araz Rawshani, Sahlgrenska Academy at the University of Gothenburg. Photo by Charlotta Sjöstedt

News | Sudden Cardiac Arrest

Cardiac Arrest Survival Rate Rising

September 9, 2022 — The probability of surviving sudden cardiac arrest outside hospital has more than doubled in 30 ...

September 09, 2022

Sponsored Content

Case Study | Hemodynamic Monitoring Systems

TECH BRIEF — Integrated Hemodynamic Monitoring System Helps Improve Lab Performance, Efficiency

Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...

November 14, 2023

investigator Michelle O’Donoghue, MD, MPH, a senior investigator of the TIMI Study Group in the Division of Cardiovascular Medicine. Image courtesy of Michelle O'Donoghue/Brigham and Women's Hospital

News | Cardiovascular Clinical Studies

FOURIER-OLE Trial Finds that Long-term Use of Evolocumab Further Reduced Cardiovascular Events

September 8, 2022 — A clinical trial led by investigators from Brigham and Women’s Hospital has found that the long-term ...

September 08, 2022

News | Remote Monitoring

Leading Cardiac Remote Monitoring Company Acquires Technology IP to Boost Its Robust Product Portfolio

September 8, 2022 — PrepMD RMS, the premier cardiac clinical solutions company, announced today the acquisition of the ...

September 08, 2022

The OCTARAY Mapping Catheter with TRUEref Technology provides physicians with the precise information needed for catheter ablation procedures that treat cardiac arrhythmias

News | Catheter

Biosense Webster Launches the OCTARAY Mapping Catheter with TRUErefTechnology

September 8, 2022 — Biosense Webster, Inc., part of Johnson & Johnson MedTech‡, announced the release of the OCTARAY ...

September 08, 2022